Viewing data from:

CIPROFLOXACIN HYDROCHLORIDE

ANDA

CIPROFLOXACIN HYDROCHLORIDE | A076593 | AIPING PHARMACEUTICAL INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CIPRO(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 4 NDCs

Highest NADAC/Unit

$0.2450

per ea

Lowest NADAC/Unit

$0.0804

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69367038750CIPROFLOXACIN HCL 750 MG TAB	$0.2450	EA	Generic	—	2026-10-21
69367038601CIPROFLOXACIN HCL 500 MG TAB	$0.1206	EA	Generic	—	2026-10-21
69367038605CIPROFLOXACIN HCL 500 MG TAB	$0.1206	EA	Generic	—	2026-10-21
69367038501CIPROFLOXACIN HCL 250 MG TAB	$0.0804	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain11 active DMFs13 inactive

11 active API suppliers hold Drug Master Files for this ingredient.

BAYER AGCIPROFLOXACIN HYDROCHLORIDE

DMF 81341989

QUIMICA SINTETICA SACIPROFLOXACIN HYDROCHLORIDE

DMF 119661996

NEULAND LABORATORIES LTDCIPROFLOXACIN HYDROCHLORIDE USP

DMF 132501998

DR REDDYS LABORATORIES LTDCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 138621998

HOLIDAY LABS MEXICO SA DE CVCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 170612003

TARO PHARMACEUTICAL INDUSTRIES LTDCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 179332004

ZHEJIANG HUAYI PHARMACEUTICAL CO LTDCIPROFLOXACIN HYDROCHLORIDE

DMF 180832004

AARTI DRUGS LTDCIPROFLOXACIN HYDROCHLORIDE

DMF 196112006

THINQ PHARMA-CRO LTDCIPROFLOXACIN HYDROCHLORIDE USP

DMF 306162016

TURTLE PHARMA PRIVATE LTDCIPROFLOXACIN HYDROCHLORIDE USP

DMF 332452018

PHLOW CORPCIPROFLOXACIN HYDROCHLORIDE USP

DMF 372062024

QUIMICA SINTETICA SAInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 85171990

CIPLA LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP IN BANGALORE, INDIA

DMF 86271990

UNION QUIMICO FARMACEUTICA SAInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 116021996

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 130721998

CIPLA LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 147092000

WOCKHARDT LTDInactiveCIPROFLOXACIN HYDROCHLORIDE, USP

DMF 149052000

MYLAN LABORATORIES LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 165442003

UNIQUE CHEMICALSInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 177862004

APITORIA PHARMA PRIVATE LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 185582005

ZHEJIANG XINHUA PHARMACEUTICAL CO LTDInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 198762006

ZHEJIANG JINGXIN PHARMACEUTICAL CO LTDInactiveCIPROFLOXACIN HYDROCHLORIDE

DMF 203372007

INDOCO REMEDIES LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 219092008

SMRUTHI ORGANICS LTDInactiveCIPROFLOXACIN HYDROCHLORIDE USP

DMF 246362011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 15, 2004	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#002 — EQ 250MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 9, 2004

No patent or exclusivity listings for this strength.

#003 — EQ 500MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 9, 2004

#004 — EQ 750MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 9, 2004